Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZNF236 Inhibitors

ZNF236 inhibitors represent a class of chemical compounds designed to modulate the activity of ZNF236, a zinc finger protein that belongs to the broader family of C2H2-type zinc finger proteins. Zinc finger proteins are a diverse group of transcription factors, characterized by their ability to bind DNA through zinc-coordinating motifs, which are critical for the regulation of gene expression. ZNF236 is known to contain multiple zinc finger domains, each potentially capable of interacting with specific DNA sequences, making it integral to the fine-tuning of various cellular processes, such as cell proliferation, differentiation, and chromatin remodeling. Inhibitors of ZNF236 are therefore molecules that specifically target this protein's function, generally by interfering with its zinc finger domains, preventing DNA binding or altering its interaction with co-regulatory proteins and other cellular partners.

The development of ZNF236 inhibitors involves an understanding of the structural biology of the protein, particularly the regions responsible for DNA and protein-protein interactions. Typically, these inhibitors are small molecules designed to occupy critical sites within the protein's structure, destabilizing the conformation required for proper function. In addition to small molecules, other approaches, such as peptide inhibitors or synthetic molecules, might also be used to target the interaction surfaces of ZNF236. The specificity of these inhibitors depends heavily on their ability to distinguish between ZNF236 and other related zinc finger proteins, due to the highly conserved nature of zinc finger motifs across this protein family. Structural studies using techniques like X-ray crystallography and nuclear magnetic resonance (NMR) play a significant role in understanding how ZNF236 interacts with its inhibitors, aiding in the design of more selective and potent molecules.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can affect protein degradation processes, possibly influencing ZNF236 levels.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

PI3K inhibitor that can impact various cellular signaling cascades and thereby influence ZNF236 activity.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

MEK inhibitor, potentially affecting pathways where ZNF236 plays a role.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$82.00
$216.00
$416.00
48
(1)

Inhibitor of the TGF-beta pathway which might be indirectly associated with ZNF236 function.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that potentially affects pathways or processes where ZNF236 is involved.

IWP-2

686770-61-6sc-252928
sc-252928A
5 mg
25 mg
$96.00
$292.00
27
(1)

Wnt production inhibitor that can affect the Wnt signaling pathway and its associated proteins, including possibly ZNF236.

EPZ6438

1403254-99-8sc-507456
1 mg
$66.00
(0)

EZH2 inhibitor, altering histone methylation which can indirectly influence ZNF236-associated transcription.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$62.00
$85.00
$356.00
155
(1)

NF-κB inhibitor affecting the NF-κB signaling pathway, which could indirectly influence ZNF236 activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

JNK inhibitor which can affect the JNK signaling pathway, possibly influencing processes where ZNF236 plays a role.